Next Article in Journal
Erratum: Ksiksi, T., et al. Antioxidant, Lipoxygenase and Histone Deacetylase Inhibitory Activities of Acridocarpus orientalis from Al Ain and Oman. Molecules 2012, 17, 12521–12532.
Next Article in Special Issue
Synthesis and Study of Fe-Doped Bi2S3 Semimagnetic Nanocrystals Embedded in a Glass Matrix
Previous Article in Journal
New Heterofunctional Supports Based on Glutaraldehyde-Activation: A Tool for Enzyme Immobilization at Neutral pH
Previous Article in Special Issue
Nanocrystalline TiO2 Composite Films for the Photodegradation of Formaldehyde and Oxytetracycline under Visible Light Irradiation
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

An All-Nanocrystal Biosensing System for In Vitro Detection of STAT3 Oligonucleotides

1
Department of Physics and Materials Science, City University of Hong Kong, 83 Tat Chee Avenue, Hong Kong, China
2
City University of Hong Kong Shenzhen Research Institute, Shenzhen 518057, China
*
Author to whom correspondence should be addressed.
Molecules 2017, 22(7), 1085; https://doi.org/10.3390/molecules22071085
Submission received: 19 May 2017 / Revised: 26 June 2017 / Accepted: 27 June 2017 / Published: 29 June 2017
(This article belongs to the Special Issue Nanocrystals: Synthesis, Characterization and Applications)

Abstract

:
Lanthanide-doped nanocrystals have shown great promise in bio-detection due to their outstanding luminescent properties, including large Stokes shift and sharp emission bands. Herein, we describe an in vitro detection of STAT3 by using an all-nanocrystal biosensing system that takes advantage of inter-particle energy transfer between two types of lanthanide-doped nanocrystals. We investigate the effect of nanocrystal size on the sensing performance and find that smaller nanocrystals offer a lower detection limit and larger dynamic range. As STAT3 is identified as an oncogene aberrantly activated and expressed in malignant transformation and tumorigenesis, our study thus holds promise for cancer diagnosis and therapy.

1. Introduction

Lanthanide-doped luminescent nanocrystals that display highly tunable emissions have attracted numerous research interests in biological labelling [1,2], lasing [3,4], and solar energy conversion [5,6,7]. With transitions occurring within the 4f configuration that is shielded by the 5s2 and 5p6 shells, lanthanide-doped nanocrystals give rise to long excited-state lifetime, large Stokes and anti-Stokes shifts, sharp and narrow emission bands, and high photochemical stability. These attributes are particularly useful for bio-applications, as they can render high signal-to-noise ratio and minimize adverse biological effects [8,9,10,11]. Specifically, fluorescence resonance energy transfer (FRET)-based biosensing systems that use lanthanide-doped nanocrystals as energy donor in conjunction with organic dyes as an energy acceptor have been intensively studied [12,13,14,15,16]. However, these systems typically suffer from problems associated with organic dyes, such as low stability as well as broad absorption and emission bands that complicate interpretation of the spectra.
During the course of our investigation on energy migration in nanostructured materials, we discovered that energy transfer can be realized across two sets of nanoparticles comprising different lanthanide dopants [17]. The inter-particle energy transfer is dominated by the network of Gd3+ ions in the host lattice, which shortens the interaction distance between the donor and the acceptor. The findings have led to the development of a new class of biotin sensor consisting of lanthanide-doped nanoparticle probes [17]. Despite the encouraging achievements, further progress in utilizing such a biosensing system is constrained by the high detection limit and small dynamic range. In addition, the versatility of the biosensing system for detecting other molecules is largely unexplored.
In this article, we describe a new class of DNA sensing system through the use of lanthanide-doped nanoparticles as both energy donor and acceptor. We also investigate the effects of nanoparticle size and concentration on the detection performance. The nanocrystals are functionalized with oligonucleotides that specifically bind to STAT3 (Figure 1). As an important member of the signal transducers and activators of transcription (STAT) protein family [18,19,20], STAT3 expression and signalling have been identified in tumours of the breast, ovary, pancreas, prostate, and melanoma. Based on recent research, the activation of STATs is tumour-specific and may represent a novel molecular target for the therapy and early diagnosis of tumours [21]. This study not only promotes the application of lanthanide-doped nanocrystals in biosensing, but also provides a promising means for the early diagnosis of tumours.

2. Results and Discussion

Lanthanide-doped NaGdF4 nanoparticles of varying sizes and dopant compositions were synthesized using a modified literature method by precipitating lanthanide ions with fluoride in organic solvents [22]. The small NaGdF4 nanoparticles (~8 nm) were synthesized in a ternary solvent mixture of oleyamine, oleic acid, and 1-octadecene, and the large NaGdF4 nanoparticles (~20 nm) were synthesized in a binary solvent mixture of oleic acid and 1-octadecene. The size control was dominated by oleyamine, which decreases the growth rate of hexagonal phase NaGdF4, according to a previous study [23]. As is shown in Figure 2, the as-synthesized nanocrystals all show uniform morphology and narrow size distribution. The average sizes of NaGdF4:Ce (15%) and NaGdF4:Tb (15%) synthesized in the presence of oleyamine were 6.5 nm and 8 nm, respectively, while the average sizes of NaGdF4:Ce (15%) and NaGdF4:Tb (15%) synthesized in the absence of oleyamine were 19 nm and 20 nm, respectively. The nanocrystals were further characterized by X-ray diffraction, and the results are shown in Figure 3. All samples exhibit diffraction patterns that can be easily indexed in accordance with hexagonal phase NaGdF4 crystals, suggesting high crystallinity and the single phase of the products.
To functionalize the lanthanide-doped nanocrystals, oleyamine/oleate ligands capped on the as-synthesized nanocrystals were first exchanged with poly (acrylic acid) (PAA) molecules using a general strategy developed by our group [24]. In brief, this ligand exchange procedure comprises two steps; i.e., removal of origin hydrophobic ligands by ultra-sonication in hydrochloric acid solution and anchoring of PAA molecules onto the surface of the ligand-free nanocrystals through solvothermal treatment in diethylene glycol (Figure 4a). Fourier transform infrared (FTIR) spectra of the nanocrystals at different stages of the ligand exchange process are shown in Figure 4b. The spectra clearly show the successful attachment of PAA molecules as evidenced by the characteristic absorption bands at 2957 and 2925 cm−1 (asymmetric and symmetric stretching vibrations of CH2), 1638 cm−1 (asymmetric stretching vibration of CO2), and 1563 cm−1 (asymmetric stretching vibration of CO). The successful modification of PAA on the nanoparticle surface was further confirmed by zeta potential measurements (Table 1), which detect negative charges from the carboxylate groups.
After surface modification with PAA, capture oligonucleotides were conjugated with the nanoparticles (Figure 4a). In detail, the conjugation was accomplished by coupling the amino group of the capture oligonucleotides with the carboxylic group of PAA on the nanocrystal surface under the catalysis of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) and N-hydroxysuccinimide (NHS) in a phosphate-buffered saline (PBS) buffer solution. The successful DNA conjugation was confirmed by a shift in surface charge as revealed by zeta potential measurements (Table 1).
The performance of the biosensing system for STAT3 detection was evaluated in a standard in vitro assay at a nanoparticle concentration of 12.5 mM. Typically, capture DNA-conjugated NaGdF4:Ce and NaGdF4:Tb nanocrystals were first mixed in an aqueous solution. Prior to the addition of targeted DNA, the Tb3+ ions showed hardly any emission upon excitation into the Ce3+ ions at 254 nm. By addition of target DNA of increasing concentrations, the emission bands of Tb3+ ions at 490 nm (5D47F6), 545 nm (5D47F5), 586 nm (5D47F4), and 620 nm (5D47F3) ascended steadily due to the formation of DNA duplexes that bring the donor and acceptor nanocrystals into close proximity, enhancing the energy transfer processes (Figure 5a,c). At substantially high concentrations of target DNA, the Tb3+ emission is saturated due to the consumption of all free nanocrystals in the solution by forming DNA duplexes. By correlating the emission intensity of Tb3+ with the concentration of target DNA, we determined a dynamic range of 0–330 nM for the biosensing system using small-sized nanoparticle probes (Figure 5a,b). In addition, the detection limit of the assay—corresponding to an analyte concentration that provides a signal three times the standard deviation above the signal of the control experiments—was estimated to be 6.35 nM. In comparative experiments using large-sized nanoparticle probes, a dynamic range of 0–230 nM and a detection limit of 70.83 nM were determined, respectively (Figure 5c,d).
The better performance (i.e., large dynamic range and low detection limit) achieved with the small-sized nanoparticle probes was ascribed to the higher surface-to-volume ratio, which results in a more effective inter-particle energy transfer and a high capacity to bind target DNA. As illustrated in Figure 6, a higher fraction of optical centres in the small-sized nanoparticles participate in the energy transfer process when compared to that in the large-sized nanoparticles. Therefore, the small-sized nanoparticle probes render a higher signal intensity than the large-sized nanoparticle probes at the same concentration of target DNA. Furthermore, the small-sized nanoparticles have a higher surface area than the large-sized nanoparticles at the same nanoparticle concentration, as confirmed by nitrogen physisorption measurements (125.4 versus 55.4 m2·g−1). Accordingly, the small-sized nanoparticle probes capture a larger amount of target DNA than the large-sized nanoparticle probes when all the free nanoparticles are consumed.
In a further set of experiments, we investigated the effect of nanoparticle concentration on the sensing performance using small-sized nanoparticle probes. As shown in Figure 7, a reduction in the nanoparticle concentration to 6.25 mM resulted in a smaller dynamic range of 0–82 nM, which is ascribed to a reduced capacity of the nanoparticle probes to bind target DNA. Nevertheless, a lower detection limit of 1.08 nM was achieved with the diluted sensor system, which is comparable to what has been achieved with conventional sensing systems [25,26,27,28]. At a reduced nanoparticle concentration, a small amount of target DNAs bring a high fraction of nanoparticles into close proximity, leading to enhanced responses of the system.
We also conducted an interference study involving DNA strands of random sequences and bovine serum albumin (BSA). Emission spectra in Figure 8 reveal that the sensing response is highly specific to the target DNA, which demonstrates high resistance of the sensing system to interference.

3. Materials and Methods

3.1. Reagents

Gadolinium(III) acetate hydrate (99.9%), cerium(III) acetate hydrate (99.9%), terbium(III) acetate hydrate (99.9%), sodium hydroxide (NaOH, 98+%), ammonium fluoride (NH4F, 98+%), 1-octadecene (90%), oleic acid (90%), oleyamine (98+%), poly(acrylic acid) (PAA, MW ≈ 1800), phosphate-buffered saline (PBS), 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (98+%) and N-hydroxysuccinimide (98%) were purchased from Sigma-Aldrich (Shanghai, China). Targeted DNA oligonucleotide (5′-TCCCTGGACTTGATCTGCTG-3′) and amine-modified capture DNA oligonucleotides (5′-AGTCCAGGGA-NH2-3′ and 5′-NH2-CAGCAGATCA-3′) were purchased from Sangon Biotech (Shanghai, China) Co., Ltd. All reagents were used as received without further purifications.

3.2. Synthesis of Small NaGdF4:Ln (15%) (Ln = Ce and Tb) Nanocrystals

In a typical procedure, 2 mL water solution of Ln(CH3CO2)3 (0.2 M, Ln = Gd, Ce and Tb) was added to a 50 mL flask containing 2 mL of oleyamine, 3 mL of oleic acid, and 5 mL of 1-octadecene. The mixture was heated at 150 °C for 40 min to form the lanthanide–oleate complexes and then cooled down to 50 °C naturally. Thereafter, 5 mL of methanol solution containing NH4F (1.55 mmol) and NaOH (1 mmol) was added and the resultant solution was stirred for 30 min. After the methanol was evaporated, the solution was heated to 290 °C under argon for 1 h and then cooled down to room temperature. The resulting nanocrystals were precipitated by the addition of ethanol, collected by centrifugation at 6000 rpm for 5 min, washed with ethanol several times, and re-dispersed in 2 mL of cyclohexane.

3.3. Synthesis of Large NaGdF4:Ln (15%) (Ln = Ce and Tb) Nanocrystals

In a typical procedure, 2 mL water solution of Ln(CH3CO2)3 (0.2 M, Ln = Gd, Ce and Tb) was added to a 50 mL flask containing 4 mL of oleic acid and 6 mL of 1-octadecene. The mixture was heated at 150 °C for 40 min to form the lanthanide–oleate complexes and then cooled down to 50 °C naturally. Thereafter, 5 mL of methanol solution containing NH4F (1.55 mmol) and NaOH (1 mmol) was added and the resultant solution was stirred for 30 min. After the methanol was evaporated, the solution was heated to 290 °C under argon for 1 h and then cooled down to room temperature. The resulting nanocrystals were precipitated by the addition of ethanol, collected by centrifugation at 6000 rpm for 5 min, washed with ethanol several times, and re-dispersed in 2 mL of cyclohexane.

3.4. Synthesis of Ligand-Free Nanocrystals

One millilitre of a cyclohexane dispersion of the as-synthesized nanocrystals was precipitated by the addition of ethanol and re-dispersed in 2 mL of HCl solution (0.1 M in deionized water). The slurry was then sonicated at 45 °C for 1 h to remove the oleate ligands. After the reaction, the nanocrystals were collected via centrifugation at 14,000 rpm for 30 min, washed with deionized water twice, and re-dispersed in 1 mL deionized water.

3.5. Surface Modification of Nanocrystals with PAA

Typically, 50 mg of PAA molecules was dissolved in 9 mL of deionized water by adjusting the pH to 8 using NaOH solution (0.1 M in deionized water) under vigorous stirring at room temperature. Thereafter, 0.5 mL of ligand-free nanocrystals was added dropwise, followed by stirring for another 2 h. The water dispersion was then added to 10 mL of diethylene glycol (DEG) and the mixture was stirred at 105 °C for 1 h to remove water. Finally, the DEG dispersion was transferred to a 20 mL Teflon-lined autoclave and incubated at 160 °C for 2 h. The obtained nanocrystals were collected via centrifugation at 14,000 rpm for 30 min, washed with ethanol and deionized water several times, re-dispersed in 8 mL of deionized water, and stored in a fridge at 4 °C.

3.6. Synthesis of Capture DNA-Conjugated Nanocrystals

The bioconjugation of capture DNA with PAA-modified nanocrystals was conducted in the presence of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) and N-hydroxysuccinimide (NHS). Typically, 1 mL of PAA capped-nanocrystals (12.5 mM) were mixed with 1 mmol NHS and 1.5 mmol EDC in 2.5 mL of PBS buffer solution (pH = 7). After stirring for 2 h, 1 mmol of capture DNA was added and the mixture was stirred for another 24 h. The capture DNA-conjugated nanocrystals were precipitated by centrifugation at 14,000 rpm and purified by washing with a mixture of water and ethanol (v/v = 1/1) twice. Finally, the DNA nanoconjugates were re-dispersed in 1 mL PBS buffer (pH = 7) for subsequent use in hybridization assays.

3.7. Detection of STAT3 by In Vitro Assay

Capture-DNA conjugated NaGdF4:Ce and NaGdF4:Tb nanocrystals (12.5 mM, 0.1 mL each) were mixed by stirring for 15 min. Then 0.1 mL of target-DNA of varying concentrations was added. After incubation for 1 h, the resultant mixture was subjected to spectroscopic examination in a quartz cuvette with 1 mm optical length under excitation at 255 nm.

3.8. Characterizations

Transmission electron microscopy (TEM) measurements were carried out on a Philips CM-20 transmission electron microscope (Philips, Amsterdam, Netherlands) operating at an acceleration voltage of 200 kV. Photoluminescence spectra were obtained from water dispersion of the nanocrystals (0.1 wt %) on a Hitachi F-4600 spectrophotometer (Hitachi, Tokyo, Japan). Zeta potential measurements were carried out on a Malvern Zetasizer Nano ZS (Malvern, Worcestershire, UK). Powder X-ray diffraction (XRD) pattern was collected on a Bruker AXS D2 Phaser X-ray diffractometer (Bruker, Karlsruhe, Germany) with Cu Kα1 radiation (λ = 0.154 nm). Fourier transform infrared (FTIR) spectra were obtained on a PE Spectrum 100 (PerkinElmer, Waltham, MA, USA). Nitrogen physisorption measurements were conducted at 77 K on automatic Nova 1200e (Quantachrome Instrument, Boynton Beach, FL, USA).

4. Conclusions

In conclusion, we have developed an all-nanocrystal biosensing system for the effective detection of a tumour-specific growth factor STAT3 DNA. The biosensing system takes advantage of inter-particle energy transfer from NaGdF4:Ce nanocrystals to NaGdF4:Tb nanocrystals that are enabled by the gadolinium host lattice. We find that small-sized nanoparticle probes provide a more effective inter-particle energy transfer and a high capacity to bind target DNA, thereby rendering a better detection performance. By using sub-10 nm NaGdF4 nanoparticle probes, we achieve a detection limit of 1.08 nM for STAT3 oligonucleotide. The current system can be readily adapted to detect other biomolecules through adjustment of the surface functionalization. Further improvement in the detection performance can be expected by using upconversion donors in combination with the optimization of nanoparticle size and concentration.

Acknowledgments

This work was supported by the National Natural Science Foundation of China (No. 21573185 and 51332008) and the Research Grants Council of Hong Kong (CityU 11208215).

Author Contributions

W.K. and F.W. conceived the experiments and wrote the paper. W.K. and C.L. were responsible for the nanocrystal synthesis and DNA detection. All authors contributed to the analysis of this manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Chen, G.; Shen, J.; Ohulchanskyy, T.Y.; Patel, N.J.; Kutikov, A.; Li, Z.; Song, J.; Pandey, R.K.; Ågren, H.; Prasad, P.N.; et al. (α-NaYbF4:Tm3+)/CaF2 Core/Shell Nanoparticles with Efficient Near-Infrared to Near-Infrared Upconversion for High-Contrast Deep Tissue Bioimaging. ACS Nano 2012, 6, 8280–8287. [Google Scholar] [CrossRef] [PubMed]
  2. Park, Y.I.; Lee, K.T.; Suh, Y.D.; Hyeon, T. Upconverting Nanoparticles: A Versatile Platform for Wide-Dield Two-Photon Microscopy and Multi-Modal in Vivo Imaging. Chem. Soc. Rev. 2015, 44, 1302–1317. [Google Scholar] [CrossRef] [PubMed]
  3. Chen, X.; Jin, L.; Kong, W.; Sun, T.; Zhang, W.; Liu, X.; Fan, J.; Yu, S.F.; Wang, F. Confining Energy Migration in Upconversion Nanoparticles towards Deep Ultraviolet Lasing. Nat. Commun. 2016, 7, 10304–10310. [Google Scholar] [CrossRef] [PubMed]
  4. Jin, L.M.; Chen, X.; Chun, K.S.; Wang, F.; Yu, S.F. Enhancing Multiphoton Upconversion from NaYF4:Yb/Tm@NaYF4 Core-Shell Nanoparticles via the Use of Laser Cavity. ACS Nano 2017, 11, 843–849. [Google Scholar] [CrossRef] [PubMed]
  5. He, M.; Pang, X.; Liu, X.; Jiang, B.; He, Y.; Snaith, H.; Lin, Z. Monodisperse Dual-Functional Upconversion Nanoparticles enabled Near-Infrared Organolead Halide Perovskite Solar Cells. Angew. Chem. Int. Ed. 2016, 55, 4280–4284. [Google Scholar] [CrossRef] [PubMed]
  6. Chang, J.; Ning, Y.; Wu, S.; Niu, W.; Zhang, S. Effectively Utilizing NIR Light Using Direct Electron Injection from Up-Conversion Nanoparticles to the TiO2 Photoanode in Dye-Sensitized Solar Cells. Adv. Funct. Mater. 2013, 23, 5910–5915. [Google Scholar] [CrossRef]
  7. Oppong, S.O.B.; Anku, W.W.; Shukla, S.K.; Govender, P.P. Lanthanum doped-TiO2 decorated on graphene oxide nanocomposite: A photocatalyst for enhanced degradation of acid blue 40 under simulated solar lightAdvanced. Adv. Mater. Lett. 2017, 8, 295–302. [Google Scholar] [CrossRef]
  8. Ong, L.C.; Ang, L.Y.; Alonso, S.; Zhang, Y. Bacterial Imaging with Photostable Upconversion Fluorescent Nanoparticles. Biomaterials 2014, 35, 2987–2998. [Google Scholar] [CrossRef] [PubMed]
  9. Tsang, M.-K.; Ye, W.; Wang, G.; Li, J.; Yang, M.; Hao, J. Ultrasensitive Detection of Ebola Virus Oligonucleotide Based on Upconversion Nanoprobe/Nanoporous Membrane System. ACS Nano 2016, 10, 598–605. [Google Scholar] [CrossRef] [PubMed]
  10. Liu, J.; Bu, W.; Pan, L.; Shi, J. NIR-Triggered Anticancer Drug Delivery by Upconverting Nanoparticles with Integrated Azobenzene-Modified Mesoporous Silica. Angew. Chem. Int. Ed. 2013, 52, 4375–4379. [Google Scholar] [CrossRef] [PubMed]
  11. Ai, F.; Sun, T.; Xu, Z.; Wang, Z.; Kong, W.; To, M.W.; Wang, F.; Zhu, G. An Upconversion Nanoplatform for Simultaneous Photodynamic Therapy and Pt Chemotherapy to Combat Cisplatin Resistance. Dalton Trans. 2016, 45, 13052–13060. [Google Scholar] [CrossRef] [PubMed]
  12. Wang, Y.; Shen, P.; Li, C.; Wang, Y.; Liu, Z. Upconversion Fluorescence Resonance Energy Transfer Based Biosensor for Ultrasensitive Detection of Matrix Metalloproteinase-2 in blood. Anal. Chem. 2012, 84, 1466–1473. [Google Scholar] [CrossRef] [PubMed]
  13. Ding, Y.; Zhu, H.; Zhang, X.; Zhu, J.; Burda, C. Rhodamine B Derivative-Functionalized Upconversion Nanoparticels for FRET-based Fe3+-sensing. Chem. Commun. 2013, 49, 7797–7799. [Google Scholar] [CrossRef] [PubMed]
  14. Lee, J.; Yoo, B.; Lee, H.; Cha, G.; Lee, H.-S.; Cho, Y.; Kim, S.Y.; Seo, H.; Lee, W.; Son, D.; et al. Ultra-Wideband Multi-Dye-Sensitized Upconverting Nanoparticles for Information Security Application. Adv. Mater. 2017, 29, 1603169–1603176. [Google Scholar] [CrossRef] [PubMed]
  15. Tu, D.; Liu, L.; Ju, Q.; Liu, Y.; Zhu, H.; Li, R.; Chen, X. Time-resolved FRET Biosensor Based on Amine-Functionalized Lanthanide-Doped NaYF4 Nanocrystals. Angew. Chem. Int. Ed. 2011, 50, 6306–6310. [Google Scholar] [CrossRef] [PubMed]
  16. Zheng, W.; Zhou, S.; Chen, Z.; Hu, P.; Liu, Y.; Tu, D.; Zhu, H.; Li, R.; Huang, M.; Chen, X. Sub-10 nm Lanthanide-Doped CaF2 Nanoprobes for Time-Resolved Luminescent Biodetection. Angew. Chem. Int. Ed. 2013, 52, 6671–6676. [Google Scholar] [CrossRef] [PubMed]
  17. Peng, D.; Ju, Q.; Chen, X.; Ma, R.; Chen, B.; Bai, G.; Hao, J.; Qiao, X.; Fan, X.; Wang, F. Lanthanide-Doped Energy Cascade Nanoparticles: Full Spectrum Emission by Single Wavelength Excitation. Chem. Mater. 2015, 27, 3115–3120. [Google Scholar] [CrossRef]
  18. Lee, S.O.; Lou, W.; Qureshi, K.M.; Mehraein-Ghomi, F.; Trump, D.L.; Gao, A.C. RNA interference targeting Stat3 inhibits growth and induces apoptosis of human prostate cancer cells. Prostate 2004, 60, 303–309. [Google Scholar] [CrossRef] [PubMed]
  19. Bromberg, J.F.; Wrzeszczynska, M.H.; Devgan, G.; Zhao, Y.; Pestell, R.G.; Albanese, C.; Darnell, J.E. Stat3 as an Oncogene. Cell 1999, 98, 295–303. [Google Scholar] [CrossRef]
  20. Lassmann, S.; Schuster, I.; Walch, A.; Gobel, H.; Jutting, U.; Makowiec, F.; Hopt, U.; Werner, M. STAT3 mRNA and protein expression in colorectal cancer: Effects on STAT3-inducible targets linked to cell survival and proliferation. J. Clin. Pathol. 2007, 60, 173–179. [Google Scholar] [CrossRef] [PubMed]
  21. Hong, D.; Kurzrock, R.; Kim, Y.; Woessner, R.; Younes, A.; Nemunaitis, J.; Fowler, N.; Zhou, T.; Schmidt, J.; Jo, M.; et al. AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer. Sci. Transl. Med. 2015, 7, 314ra185. [Google Scholar] [CrossRef] [PubMed]
  22. Wang, F.; Deng, R.; Liu, X. Preparation of Core-Shell NaGdF4 Nanoparticles Doped with Luminescent Lanthanide Ions to Be Used as Upconversion-Based Probes. Nat. Protoc. 2014, 9, 1634–1644. [Google Scholar] [CrossRef] [PubMed]
  23. Mai, H.-X.; Zhang, Y.-W.; Si, R.; Yan, Z.-G.; Sun, L.-D.; You, L.-P.; Yan, C.-H. High-Quality Sodium Rare-Earth Fluoride Nanocrystals: Controlled Synthesis and Optical Properties. J. Am. Chem. Soc. 2006, 128, 6426–6436. [Google Scholar] [CrossRef] [PubMed]
  24. Kong, W.; Sun, T.; Chen, B.; Chen, X.; Ai, F.; Zhu, X.; Li, M.; Zhang, W.; Zhu, G.; Wang, F. A General Strategy for Ligand Exchange on Upconversion Nanoparticles. Inorg. Chem. 2017, 56, 872–877. [Google Scholar] [CrossRef] [PubMed]
  25. Ju, Q.; Chen, X.; Ai, F.; Peng, D.; Lin, X.; Kong, W.; Shi, P.; Zhu, G.; Feng, W. An Upconversion Nanoprobe Operating in the First Biological Window. J. Mater. Chem. B 2015, 3, 3548–3555. [Google Scholar] [CrossRef]
  26. Zhang, C.; Yuan, Y.; Zhang, S.; Wang, Y.; Liu, Z. Biosensing Platform Based on Fluorescence Resonance energy Transfer from Upconverting Nanocrystals to Graphene Oxide. Angew. Chem. Int. Ed. 2011, 50, 6851–6854. [Google Scholar] [CrossRef] [PubMed]
  27. Wang, Y.; Wu, Z.; Liu, Z. Upconversion fluorescence resonance energy transfer biosensor with aromatic polymer nanospheres as the lable-free energy acceptor. Anal. Chem. 2013, 85, 258–264. [Google Scholar] [CrossRef] [PubMed]
  28. Zhu, H.; Lu, F.; Wu, X.-C.; Zhu, J.-J. An Upconversion Fluorescent Resonant Energy Transfer Biosensor for Hepatitis B virus (HBV) DNA Hybridization Detection. Analyst 2015, 140, 7622–7628. [Google Scholar] [CrossRef] [PubMed]
Sample Availability: Samples of the nanocrystals are available from the authors.
Figure 1. (a) Schematic illustration of the experimental design for DNA detection using oligonucleotide-functionalized nanoparticle probes; (b) Proposed energy transfer mechanism between NaGdF4:Ce and NaGdF4:Tb nanoparticles.
Figure 1. (a) Schematic illustration of the experimental design for DNA detection using oligonucleotide-functionalized nanoparticle probes; (b) Proposed energy transfer mechanism between NaGdF4:Ce and NaGdF4:Tb nanoparticles.
Molecules 22 01085 g001
Figure 2. TEM image of the as-synthesized nanocrystals. (a,b) NaGdF4:Ce (15%) and NaGdF4:Tb (15%) nanocrystals synthesized in oleyamine/oleic acid/1-octadecene; (c,d) NaGdF4:Ce (15%) and NaGdF4:Tb (15%) nanocrystals synthesized in oleic acid/1-octadecene.
Figure 2. TEM image of the as-synthesized nanocrystals. (a,b) NaGdF4:Ce (15%) and NaGdF4:Tb (15%) nanocrystals synthesized in oleyamine/oleic acid/1-octadecene; (c,d) NaGdF4:Ce (15%) and NaGdF4:Tb (15%) nanocrystals synthesized in oleic acid/1-octadecene.
Molecules 22 01085 g002
Figure 3. XRD pattern of the as-synthesized nanocrystals. (a) NaGdF4:Ce (15%) and NaGdF4:Tb (15%) nanocrystals synthesized in oleyamine/oleic acid/1-octadecene; (b) NaGdF4:Ce (15%) and NaGdF4:Tb (15%) nanocrystals synthesized in oleic acid/1-octadecene. The line spectra are literature data for hexagonal phase NaGdF4 crystals (Joint Committee on Powder Diffraction Standards file number 27-0699).
Figure 3. XRD pattern of the as-synthesized nanocrystals. (a) NaGdF4:Ce (15%) and NaGdF4:Tb (15%) nanocrystals synthesized in oleyamine/oleic acid/1-octadecene; (b) NaGdF4:Ce (15%) and NaGdF4:Tb (15%) nanocrystals synthesized in oleic acid/1-octadecene. The line spectra are literature data for hexagonal phase NaGdF4 crystals (Joint Committee on Powder Diffraction Standards file number 27-0699).
Molecules 22 01085 g003
Figure 4. (a) Schematic illustration of the procedure of surface modification and DNA conjugation; (b) Fourier transform infrared (FTIR) spectra of ligand-free (black) and poly (acrylic acid) (PAA, red) modified nanocrystals with size of sub-10 nm (the first two) and over-10 nm (the last two). EDC: 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide; NHS: N-hydroxysuccinimide; PBS: phosphate-buffered saline.
Figure 4. (a) Schematic illustration of the procedure of surface modification and DNA conjugation; (b) Fourier transform infrared (FTIR) spectra of ligand-free (black) and poly (acrylic acid) (PAA, red) modified nanocrystals with size of sub-10 nm (the first two) and over-10 nm (the last two). EDC: 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide; NHS: N-hydroxysuccinimide; PBS: phosphate-buffered saline.
Molecules 22 01085 g004
Figure 5. A comparison of the sensing performance by using small- and large-sized nanoparticle bioprobes (nanoparticle concentrations are fixed at 12.5 mM). (a) Emission spectra of the biosensing system composed of small-sized nanoparticle probes in the presence of varying concentrations of target DNA (nM); (b) Emission intensity of Tb3+ at 545 nm as a function of target DNA concentration from 0–660 nM. The straight line is a linear regression of the measured data in the DNA concentration range of 0–330 nM. The dashed curve marks the concentration range that deviates from the linear regression; (c) Emission spectra of the biosensing system composed of large-sized nanoparticle probes in the presence of varying concentrations of target DNA (nM) (d) Emission intensity of Tb3+ at 545 nm as a function of target DNA concentration from 0–660 nM. The straight line is linear regression of the measured data in a DNA concentration range of 0–230 nM. The dashed curve marks the concentration range that deviates from the linear regression. All the error bars shown represent the standard deviations from three sets of repeated measurements.
Figure 5. A comparison of the sensing performance by using small- and large-sized nanoparticle bioprobes (nanoparticle concentrations are fixed at 12.5 mM). (a) Emission spectra of the biosensing system composed of small-sized nanoparticle probes in the presence of varying concentrations of target DNA (nM); (b) Emission intensity of Tb3+ at 545 nm as a function of target DNA concentration from 0–660 nM. The straight line is a linear regression of the measured data in the DNA concentration range of 0–330 nM. The dashed curve marks the concentration range that deviates from the linear regression; (c) Emission spectra of the biosensing system composed of large-sized nanoparticle probes in the presence of varying concentrations of target DNA (nM) (d) Emission intensity of Tb3+ at 545 nm as a function of target DNA concentration from 0–660 nM. The straight line is linear regression of the measured data in a DNA concentration range of 0–230 nM. The dashed curve marks the concentration range that deviates from the linear regression. All the error bars shown represent the standard deviations from three sets of repeated measurements.
Molecules 22 01085 g005
Figure 6. Schematic illustration comparing the inter-particle energy transfer for small- and large-sized nanoparticle probes.
Figure 6. Schematic illustration comparing the inter-particle energy transfer for small- and large-sized nanoparticle probes.
Molecules 22 01085 g006
Figure 7. The performance of the biosensing system by using a low concentration of nanoparticle probes (6.25 mM). (a) Emission spectrum of the nanoparticle dispersion in the presence of varying concentrations of target DNA (nM); (b) Emission intensity of Tb3+ at 545 nm as a function of target DNA concentration from 0–250 nM. The straight line is a linear regression of the measured data in the DNA concentration range of 0–82 nM. The dashed curve marks the concentration range that deviates from the linear regression. All the error bars shown represent the standard deviations from three sets of repeated measurements.
Figure 7. The performance of the biosensing system by using a low concentration of nanoparticle probes (6.25 mM). (a) Emission spectrum of the nanoparticle dispersion in the presence of varying concentrations of target DNA (nM); (b) Emission intensity of Tb3+ at 545 nm as a function of target DNA concentration from 0–250 nM. The straight line is a linear regression of the measured data in the DNA concentration range of 0–82 nM. The dashed curve marks the concentration range that deviates from the linear regression. All the error bars shown represent the standard deviations from three sets of repeated measurements.
Molecules 22 01085 g007
Figure 8. Emission spectra of the biosensing system in the presence of target DNA (green line), target DNA mixed with bovine serum albumin (BSA) and random DNA (purple), random DNA (red line), and BSA (blue line). The concentrations of nanoparticles and target DNAs are 6.25 mM and 12 nM, respectively. The sequences of employed random DNAs are 5′-CAAGGAGCTGGAAGGCTGGG-3′, 5′-ACATAAAGAAATCATGG-3′, and 5′-AGTTAAAGAAATCATGGAAGTAA-3′ (4 nM each).
Figure 8. Emission spectra of the biosensing system in the presence of target DNA (green line), target DNA mixed with bovine serum albumin (BSA) and random DNA (purple), random DNA (red line), and BSA (blue line). The concentrations of nanoparticles and target DNAs are 6.25 mM and 12 nM, respectively. The sequences of employed random DNAs are 5′-CAAGGAGCTGGAAGGCTGGG-3′, 5′-ACATAAAGAAATCATGG-3′, and 5′-AGTTAAAGAAATCATGGAAGTAA-3′ (4 nM each).
Molecules 22 01085 g008
Table 1. Zeta potential of the ligand-free, PAA-modified, and DNA-conjugated nanocrystals.
Table 1. Zeta potential of the ligand-free, PAA-modified, and DNA-conjugated nanocrystals.
SampleZeta-Potential/mV
Ligand-FreePAA-ModifiedDNA-Conjugated
NaGdF4:Ce (Small)47.7−10.63.71
NaGdF4:Tb (Small)52.5−23.314.2
NaGdF4:Ce (Large)46.8−5.813.04
NaGdF4:Tb (Large)48.2−13.715.0

Share and Cite

MDPI and ACS Style

Kong, W.; Lam, C.F.; Wang, F. An All-Nanocrystal Biosensing System for In Vitro Detection of STAT3 Oligonucleotides. Molecules 2017, 22, 1085. https://doi.org/10.3390/molecules22071085

AMA Style

Kong W, Lam CF, Wang F. An All-Nanocrystal Biosensing System for In Vitro Detection of STAT3 Oligonucleotides. Molecules. 2017; 22(7):1085. https://doi.org/10.3390/molecules22071085

Chicago/Turabian Style

Kong, Wei, Chau Fan Lam, and Feng Wang. 2017. "An All-Nanocrystal Biosensing System for In Vitro Detection of STAT3 Oligonucleotides" Molecules 22, no. 7: 1085. https://doi.org/10.3390/molecules22071085

Article Metrics

Back to TopTop